1 Biotech Stock to Double Down on in Q4
Published on October 26, 2022
Leading drug maker Amgen (AMGN) delivered impressive second-quarter results. The company is well-positioned for solid long-term growth, driven by its diversified and growing product portfolio, rising demand from a rapidly...